Casdin CapitalInvestor Details

Get alertedif Casdin Capital makes an investment
Casdin Capital
Want to know when Casdin Capital invests in a new company?
Tenaya Therapeutics (2021: $106,000,000 raised)
Vividion Therapeutics Inc (2021: $135,000,000 raised)
Verve Therapeutics (2021: $94,000,000 raised)
Paige (2021: $100,000,000 raised)
Octave Bioscience (2020: $32,000,000 raised)
Somalogic Inc (2020: $121,000,000 raised)
A2 Biotherapeutics (2020: $72,000,000 raised)
Thrive Earlier Detection Corp (2020: $257,000,000 raised)
Dna Script (2020: $60,913,200 raised)
Verve Therapeutics (2020: $63,000,000 raised)
Kallyope Inc (2020: $112,000,000 raised)
Amunix Pharmaceuticals Inc (2020: $73,000,000 raised)
Verana Health (2020: $100,000,000 raised)
Eqrx (2020: $200,000,000 raised)
Black Diamond Therapeutics (2019: $85,000,000 raised)
Tenaya Therapeutics (2019: $92,000,000 raised)
Sexton Biotechnologies (2019: $5,000,000 raised)
Revolution Medicines Inc (2019: $100,000,000 raised)
Thrive Earlier Detection Corp (2019: $110,000,000 raised)
Vividion Therapeutics Inc (2019: $82,000,000 raised)
Prominex (2018: $4,000,000 raised)
Genomatica (2018: $90,000,000 raised)
Fulcrum Therapeutics (2018: $80,000,000 raised)
Alector Llc (2018: $133,000,000 raised)
Lyra Health Inc (2018: $45,000,000 raised)
Revolution Medicines Inc (2018: $56,000,000 raised)
Vineti (2018: $33,500,000 raised)
Constellation Pharmaceuticals Inc (2018: $100,000,000 raised)
Magenta Therapeutics (2018: $52,000,000 raised)
Relay Therapeutics (2017: $63,000,000 raised)
Neon Therapeutics (2017: $36,000,000 raised)
Magenta Therapeutics (2017: $50,000,000 raised)
Syros Pharmaceuticals (2016: $40,000,000 raised)
Gritstone Oncology (2015: $102,000,000 raised)
908 Devices Inc (2015: $1,400,000 raised)
Jounce Therapeutics (2015: $56,000,000 raised)
Voyager Therapeutics (2015: $60,000,000 raised)
Invitae Corp (2014: $120,000,000 raised)
Blueprint Medicines (2014: $25,000,000 raised)
Foundation Medicine Inc (2012: $42,500,000 raised)
Nextech Invest Ltd
The Column Group
Third Rock Ventures Llc
Section 32
Redmile Group
Deerfield Management
ARCH Venture Partners
Bvf Partners
Foresite Capital
Polaris Partners
Versant Ventures
Access Industries
Alexandria Venture Investments
Boxer Capital Llc
Euclidean Capital
Fidelity Management & Research Company
Ra Capital Management
Wellington Management
Biomatics Capital
Cormorant Asset Management
Deerfield Management Company
Driehaus Capital Management Llc
Ecor1 Capital
Frazier Healthcare Partners
Google Ventures
Gv (formerly Google Ventures)
Illumina Ventures
Logos Capital
Lux Capital
Omega Funds
Partner Fund Management Lp
Perceptive Advisors Llc
Pharmstandard International
Roche Venture Fund
Rock Springs Capital
Schroder Adveq
T Rowe Price Associates Inc
Wellington Management Company Llp
6 Dimensions Capital
Abbvie Ventures
Acuta Capital
Agilent Technologies
Aisling Capital
Altitude Life Science Ventures
Amgen Ventures
Andreessen Horowitz Llc
Arboretum Ventures
Arrowmark Partners
Atlas Venture
Avoro Capital Advisors
Bain Capital Life Sciences
Bain Capital Ventures Llc
Be The Match Biotherapies
Bill Gates
Biocrossroads Inc
Biolife Solutions
Biotech Value Fund Lp
Biotechnology Value Fund
Blue Water Life Science Advisors
Bluecross Blueshield Venture Partners
Bpifrance Large Venture
Brook Byers
Brookside Capital
Brown Advisory
Camden Partners
Cardinal Partners
City Hill Ventures
Clarus Ventures
Cook Regentec
Cormorant Capital
Cowin Venture
Crown Venture Fund
Danaher Life Sciences
Decheng Capital
Define Ventures
Delian Capital
Echo Health Ventures
Eventide Asset Management
Exact Sciences
F-prime Capital
Farallon Capital Management Llc
Federated Kaufmann Fund
Fidelity Management
Fiscus Ventures
Gamma 3 Llc
Ge Ventures
Genesys Capital
Genomic Health Inc
Ginkgo Bioworks
Glynn Capital Management
Greenspring Associates
Hartford Healthcare Endowment
Hillhouse Capital
Hillhouse Capital Group
Intermountain Ventures
Janus Henderson Investors
Johnson & Johnson Innovation – Jjdc Inc
Kleiner Perkins Caufield & Byers
Lifeforce Capital
Lilly Asia Ventures
Longitude Capital
Madryn Asset Management
Merck Ventures
Mirae Asset Capital
Monashee Investment Management Llc
Moore Strategic Ventures
Mossrock Capital Llc
Mrl Ventures
Mubadala Capital
Mubadala Ventures
New Enterprise Associates
New Leaf Venture Partners Llc
Nextech Inves
Nextech Venture
Northpond Ventures
Ns Investment
Ns Investments Llc
Oncology Focused Investor
Ortho Clinical Diagnostics
Partners Innovation Fund
Providence Ventures Llc
Reimagined Ventures
Research Company
Rtw Investments
Samsara Biocapital
Sands Capital
Sanofi Venture
Sirona Capital
Softbank Investment Advisers
Soleus Capital
Surveyor Capital (a Citadel Company)
T.rowe Price Associates Inc
Tenaya Capital
The Blue Venture Fund
The Broe Group
The Dementia Discovery Fund
Thermo Fisher Scientific Inc
Thomas Mcnerney & Partner
Topspin Partners
Transformational Healthcare Opportunity
Trinitas Capital
Two River
Two Sigma Ventures
Uc Investments
Venrock Healthcare Partners
Vida Ventures
Viking Global Investors
Vivo Capital
Watermill Asset Management
Wellington Management Co
Wellington Management Company
Woodline Partners Lp
Wuxi Corporate Venture Fund
Wuxi Ventures Funds
This list displays investors that took part in the same funding round as Casdin Capital since March 2012. They are displayed in decreasing order of coinvesting frequency.
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!